BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1025 related articles for article (PubMed ID: 31585842)

  • 1. Suspected inflammatory rheumatic diseases in patients presenting with skin rashes.
    Alves F; Gonçalo M
    Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101440. PubMed ID: 31585842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatologic manifestations of rheumatic disorders.
    McCauliffe DP; Sontheimer RD
    Prim Care; 1993 Dec; 20(4):925-41. PubMed ID: 8310089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arthritis and skin disease.
    Angotti C
    Skinmed; 2005; 4(5):293-7. PubMed ID: 16282751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and clinical significance of anti-carbamylation protein antibodies in rheumatological diseases among the Chinese Han population.
    Dong R; Sun Y; Xu W; Xiang W; Li M; Yang Q; Zhu L; Ma Z
    Front Immunol; 2023; 14():1197458. PubMed ID: 37539050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of systemic lupus erythematosus (SLE) to rheumatoid arthritis (RA), discoid lupus erythematosus (DLE) and Sjögren's syndrome. A clinical study.
    Bencze G
    Acta Rheumatol Scand; 1970; 16(3):191-6. PubMed ID: 5488864
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurologic manifestations in rheumatic diseases].
    Kawakami A
    Rinsho Shinkeigaku; 2013; 53(7):507-12. PubMed ID: 23892960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary manifestations of the rheumatic diseases.
    Boulware DW; Weissman DN; Doll NJ
    Clin Rev Allergy; 1985 May; 3(2):249-67. PubMed ID: 3886120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin involvement and outcome measures in systemic autoimmune diseases.
    Albrecht J; Atzeni F; Baldini C; Bombardieri S; Dalakas MC; Demirkesen C; Yazici H; Mat C; Werth VP; Sarzi-Puttini P
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S52-9. PubMed ID: 16466625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
    Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
    Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular involvement in cutaneous connective tissue disease.
    Santoro FA; Huang J
    Clin Dermatol; 2016; 34(2):138-45. PubMed ID: 26903181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
    Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis?
    Tunc SE; Ertam I; Pirildar T; Turk T; Ozturk M; Doganavsargil E
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):497-503. PubMed ID: 17373977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
    Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
    Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatic syndromes: clues to occult neoplasia.
    Naschitz JE; Rosner I; Rozenbaum M; Zuckerman E; Yeshurun D
    Semin Arthritis Rheum; 1999 Aug; 29(1):43-55. PubMed ID: 10468414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.
    Andraos R; Ahmad A; Eriksson P; Dahlström Ö; Wirestam L; Dahle C; Hesselstrand R; Bengtsson AA; Jönsen A; Andréasson K; Sjöwall C
    Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the Revised Classification Criteria for Systemic Autoimmune Rheumatic Diseases and Their Overlap Syndromes.
    Inoue Y; Ogura T; Yamashita N; Takenaka S; Ito H; Hirata A; Katagiri T; Takakura Y; Imaizumi C; Mizushina K; Imamura M; Kujime R; Hayashi N; Kameda H
    Intern Med; 2022; 61(13):1947-1952. PubMed ID: 35781270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.